Skip to main content
. 2020 Jan 29;4:35. Originally published 2019 Feb 18. [Version 2] doi: 10.12688/wellcomeopenres.15011.2

Table 1. Key GBD studies from 1990 to the present.

These are the official studies indicated as such by Chris Murray and Alan Lopez in their description of the evolution of the GBD 33. Key articles and methodological changes are described here, but they are by no means exhaustive.

GBD Study
Year(s)
Years
Included
Publication
Year
Key Publications Key Authors Institutional Support Disease/ Injury
Categories
(Morbidity)
Notable Changes to the Study
1990 1990 1993 World Development
Report: Investing in
Health i
Murray, Lopez,
Jamison
World Bank, WHO, Harvard University 109
1990 1997 The Lancet Murray, Lopez WHO, World Bank, Edna
McConnell Clark Foundation,
Rockefeller Foundation
107; 483
sequelae
•Eliminated age weighting
1999–2004 1999–2004 1999–2002 World Health
Reports I, ii, iii, iv
Murray, Lopez,
Mathers,
Ma Fat
WHO •New methodologies for finding mortality ii
2004 The Global Burden
of Disease: 2004
Update
Mathers, Ma Fat WHO •Incorporated cause-specific and multicause models
– developed by the WHO Child Health Epidemiology
Reference Group (CHERG) – for causes of child deaths
under five years of age and for neonatal deaths
2010 1990, 2005,
2010
2012 The Lancet iii Murray, Lopez,
et al.
IHME; The Gates
Foundation
291; 1160
sequelae
•For the first time, quantified uncertainty for each
estimation to provide a means for the user to judge its
strength
2013 1990–2013 2014, 2015 The Lancet iv Murray, Lopez,
et al.
IHME; The Gates
Foundation
306; 2337
sequelae
•First of annual GBD updates
2015 1990–2015 2016 The Lancet v Murray, Lopez,
et al.
IHME; The Gates
Foundation
328; 2982
sequelae
•Introduction of Socio-demographic Index (SDI) based
on measures of income per capita, average years of
schooling, and total fertility rate
2016 1990–2016 2017 The Lancet vi Murray, Lopez,
et al.
IHME; The Gates
Foundation
333; 2982
sequelae
•Introduction of measuring progress of health-related
Sustainable Development Goals
•Added attention to subnational data
2017 1990–2017 2018 The Lancet vii Murray, Lopez,
et al.
IHME; The Gates
Foundation
354; 3484
sequelae
•Added “2842 collaborator-provided data sources and
incorporating new clinical data representing an additional
149 million admissions and 3.7 billion outpatient visits
for use in GBD modelling,” resulting “in a total of 68, 781
sources being used in the estimation process”

These are the GBD studies that Chris Murray and Alan Lopez indicate are the official ones in their own description of the evolution of the GBD viii. Key articles and methodological changes are cited here, but they are by no means exhaustive.

iWorld Bank: World Development Report: Investing in Health. World Development Indicators. Oxford: Oxford Univ. Press. 1993.

iWHO: The World Health Report 1999: Making a Difference. Geneva: WHO. 1999.

iiWHO: The World Health Report 2000: Health Systems: Improving Performance. Geneva: WHO. 2000.

iiiWHO: World Health Report 2001: Mental Health: New Understanding, New Hope. Geneva: WHO. 2002.

ivWHO: The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva: WHO. 2003.

iiLopez AD, Ahmad OB, Guillot M, et al.: World mortality in 2000: life tables for 191 countries. Geneva: World Health Organization. 2002.

iiiMurray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, et al.: Disability-Adjusted Life Years (DALYs) for 291 Diseases and Injuries in 21 Regions, 1990–2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet. 2012. 380 (9859): 2197–2223.

ivMurray CJL, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, Abera SF, Aboyans V, et al.: Global, Regional, and National Disability-Adjusted Life Years (DALYs) for 306 Diseases and Injuries and Healthy Life Expectancy (HALE) for 188 Countries, 1990–2013: Quantifying the Epidemiological Transition. Lancet. 2015. 386 (10009): 2145–2191.

vKassebaum NJ, Arora M, Barber RM, Bhutta ZA, Brown J, Carter A, Casey DC, et al.: Global, Regional, and National Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE), 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015. Lancet. 2016. 388 (10053): 1603–58.

viHay SI, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, et al.: Global, Regional, and National Disability-Adjusted Life-Years (DALYs) for 333 Diseases and Injuries and Healthy Life Expectancy (HALE) for 195 Countries and Territories, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet. 2017. 390 (10100): 1260–1344.

viiJames SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, et al.: Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet. 2018. 392 (10159): 1789–1858.

viiiMurray CJL, Lopez AD. Measuring Global Health: Motivation and Evolution of the Global Burden of Disease Study. Lancet. 2017. 390 (10100): 1460–64.